Atrial Fibrillation Trial, Recruiting NCT07724171 Sponsor: Yonsei University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07724171
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 19 years or older
  • People who have had a patent foramen ovale (a small hole in the heart) closed using a minimally invasive procedure through the skin (rather than open-heart surgery)
  • For the retrospective (past records) group: people whose procedure was performed between 2010 and March 2026, and who had at least one heart ultrasound using agitated saline (a bubbles test) after the procedure
  • For the prospective (ongoing) group: people whose procedure is performed after the trial receives ethical approval, and who provide written agreement to participate

Who may not be able to join:

  • People who had a different type of heart hole closed — specifically an atrial septal defect that is not a patent foramen ovale
  • People whose closure device moved out of place or had to be removed
  • People whose heart ultrasound images were not clear enough to assess whether the hole is still allowing blood flow through (confirm with trial site)
  • For the prospective group: people who do not wish to provide written agreement to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +82-2-2228-8335

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 June 2026
Est. completion
4 May 2036

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Number of participants with recurrent ischemic stroke or transient ischemic attack; Number of participants with residual right-to-left shunt on agitated saline transthoracic echocardiography, by shunt grade

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov